Fate Therapeutics (United States)
In research, Fate Therapeutics (United States) stands highest in Medicine (#17,122 of 17,978 worldwide) and Health Sciences (#19,788 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Oncology — Oncology is 23.3× its share of world research.
- World rank, 2022–2025
- #15,139 of 28,054 · #17,350 all time
- Rank in United States
- #2,139 of 4,192
- Research works
- 263 ▲ 228% vs 2013–17
- Citations
- 3.1k 11.7 per fractional work
- Top-10% rate
- 12.0% record average 16.5%
- Open access
- 40% world 28%
What is Fate Therapeutics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,122 of 17,978 | 9.9% | 126 | |
| Health SciencesDomain | #19,788 of 20,462 | 9.9% | 129 |
Each strip is that field’s whole ranked pool, with the notch where Fate Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Fate Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Oncology takes 23.3× the share of its output that it takes of world research.
- OncologySubfield · 23.0 works23×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.0×. Every wedge is a field page.
- Immunology and Microbiology 13.0×
- Biochemistry, Genetics and Molecular Biology 4.0×
- Medicine 2.7×
- Veterinary 1.2×
- Neuroscience 0.6×
- Nursing 0.5×
- Arts and Humanities 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Materials Science 0.3×
- Economics, Econometrics and Finance 0.3×
- Dentistry 0.3×
- Chemistry 0.3×
- Social Sciences 0.3×
- Computer Science 0.2×
- Health Professions 0.2×
- Engineering 0.1×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
Who are the top researchers at Fate Therapeutics (United States)?
Ranked on the composite score, Tom Lee, Bahram Valamehr and Michael P. Cooke lead among researchers whose main affiliation is Fate Therapeutics (United States).
- 1 Tom Lee United States · #262,493 worldwide 94 citations · 48 works
- 2 Bahram Valamehr United States · #793,343 worldwide 56 citations · 24 works
- 3 Michael P. Cooke United States · #838,956 worldwide 51 citations · 24 works
- 4 Rina M. Mbofung United States · #1,514,625 worldwide 5 citations · 16 works
- 5 Anthony E. Boitano United States · #1,516,461 worldwide 14 citations · 17 works
- 6 Jennifer Proctor United States · #1,602,601 worldwide 2 citations · 18 works
Which keywords describe research at Fate Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells and NK Cell Recognition.
- cancer development
- RNA-Guided
- Tumor Antigen
- Monoclonal Antibody
- Cancer Progression
- Breast Cancer
- Biosimilars
- Immunity
- Transcriptional Regulation
- Fc Receptors
- Antibody Engineering
- Phosphorylation
- Therapeutic Antibodies
- Quality of Life
- Glycosylation
- Monoclonal Antibodies
- Natural Killer Cells
- Chimeric Antigen Receptor
- Lymphoma
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- CAR T Cells
- NK Cell Recognition
- Inflammation
- Cancer
- Cancer Therapy
- Immunogenicity
- Cell Cycle Control
- Tumor Microenvironment
- Biopharmaceuticals
- Metabolism
- Innate Immunity
- Bioanalytical Methods
- Gene Therapy
- Antigen Presentation
- Cell Signaling
- Dendritic Cells
- Genome Engineering
- 14-3-3 Proteins
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy20▲ 151×3 topics
- Immunotherapy20▲ 32×7 topics
- Tumor Regression19▲ 196×2 topics
- Lymphoma18▲ 129×3 topics
- CAR T Cells18▲ 281×1 topic
- Chimeric Antigen Receptor18▲ 281×1 topic
- NK Cell Recognition6▲ 95×1 topic
- Natural Killer Cells6▲ 95×1 topic
- Inflammation5▲ 2.7×24 topics
- Monoclonal Antibodies5▲ 58×3 topics
- Cancer4▲ 3.5×13 topics
- Glycosylation3▲ 33×3 topics
- Cancer Therapy3▲ 5.9×7 topics
- Quality of Life3▲ 2.2×6 topics
- Immunogenicity2▲ 67×3 topics
- Therapeutic Antibodies2▲ 41×2 topics
- Cell Cycle Control2▲ 89×2 topics
- Phosphorylation2▲ 108×2 topics
- Tumor Microenvironment2▲ 6.1×7 topics
- Antibody Engineering2▲ 48×1 topic
- Biopharmaceuticals2▲ 50×2 topics
- Fc Receptors2▲ 48×1 topic
- Metabolism2▲ 5.1×5 topics
- Transcriptional Regulation2▲ 17×7 topics
- Innate Immunity2▲ 7.8×3 topics
- Immunity2▲ 6.0×3 topics
- Bioanalytical Methods2▲ 117×1 topic
- Biosimilars2▲ 117×1 topic
- Gene Therapy2▲ 12×4 topics
- Breast Cancer2▲ 9.2×5 topics
- Antigen Presentation2▲ 23×2 topics
- Cancer Progression2▲ 11×4 topics
- Cell Signaling2▲ 13×5 topics
- Monoclonal Antibody2▲ 40×2 topics
- Dendritic Cells2▲ 22×1 topic
- Tumor Antigen2▲ 32×1 topic
- Genome Engineering2▲ 28×1 topic
- RNA-Guided2▲ 28×1 topic
- 14-3-3 Proteins2▲ 330×1 topic
- cancer development2▲ 330×1 topic
Which research topics does Fate Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 18 works
- 2 Immune Cell Function and Interaction Immunology 6 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 4 Biosimilars and Bioanalytical Methods Immunology 2 works
- 5 Immunotherapy and Immune Responses Immunology 2 works
- 6 CRISPR and Genetic Engineering Molecular Biology 2 works
- 7 14-3-3 protein interactions Molecular Biology 2 works
- 8 Renal Diseases and Glomerulopathies Nephrology 1 works
- 9 Pluripotent Stem Cells Research Molecular Biology 1 works
- 10 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fate Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 228% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.